ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 14

$454K Total Retail Price of All Prescriptions

Rank: 3 out of 14

803 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 803 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 7,343 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 352 270 1 5
SIMVASTATIN 336 214 2 3
LEVOTHYROXINE SODIUM 320 238 3 2
METFORMIN HCL 310 229 4 8
AMOXICILLIN 302 219 5 41
OMEPRAZOLE 295 188 6 4
HYDROCODONE-ACETAMINOPHEN 257 140 S3 7 1
TRAMADOL HCL 245 163 8 11
LISINOPRIL 243 156 9 7
GABAPENTIN 214 143 10 9
MELOXICAM 179 145 11 12
GLIMEPIRIDE 171 108 12 27
FUROSEMIDE 165 130 13 6
NEXIUM 165 133 13 16
CITALOPRAM HBR 157 95 15 18
ZOLPIDEM TARTRATE 151 101 16 10
METOPROLOL SUCCINATE 147 98 17 24
AZITHROMYCIN 119 85 18 33
POTASSIUM CHLORIDE 117 87 19 15
ENALAPRIL MALEATE 116 51 20 79
LOSARTAN POTASSIUM 114 101 21 22
GEMFIBROZIL 114 86 21 82
HYDROCHLOROTHIAZIDE 103 74 23 13
ATENOLOL 101 59 24 28
CLOPIDOGREL 99 73 25 51
METOPROLOL TARTRATE 92 75 26 17
FLUTICASONE PROPIONATE 89 64 27 46
LOSARTAN-HYDROCHLOROTHIAZIDE 89 87 27 30
CARVEDILOL 89 65 27 29
SERTRALINE HCL 89 48 27 26
CIPROFLOXACIN HCL 85 62 31 47
CLONIDINE HCL 83 63 32 40
TRAZODONE HCL 82 53 33 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 51 34 14
ADVAIR DISKUS 79 43 35 103
SYNTHROID 78 78 36 34
ATORVASTATIN CALCIUM 68 50 37 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 44 38 49
BACLOFEN 65 43 39 115
BENAZEPRIL HCL 64 58 40 117
ZETIA 63 51 41 77
AMLODIPINE BESYLATE-BENAZEPRIL 62 57 42 42
RANITIDINE HCL 59 44 43 57
MUPIROCIN 58 42 44 87
PLAVIX 57 45 45 66
DOXYCYCLINE HYCLATE 53 33 46 69
LANSOPRAZOLE 52 0 47 136
PRAVASTATIN SODIUM 51 47 48 21
CYCLOBENZAPRINE HCL 51 23 R 48 52
FLUOXETINE HCL 51 46 48 71
PROMETHAZINE HCL 51 24 R 48 137
POLYETHYLENE GLYCOL 3350 50 46 52 58
TRIAMTERENE-HCTZ 50 37 52 50
PROAIR HFA 50 43 52 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.